The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer

Maturitas

Volumn 43, Issue 2, 2002, Pages 77-85

  Jongen, V H W M ^a   Sluijmer, A V ^b   Heineman, M J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Wilhelmina Ziekenhuis   (Netherlands)

Author keywords

Adrenal glands; Androgens; Endometrial cancer; Estrogens; Postmenopausal

Indexed keywords

ANASTROZOLE; ANDROGEN; AROMATASE; AROMATASE INHIBITOR; CYTOCHROME P450; ESTROGEN; LETROZOLE; MITOGENIC AGENT;

ADRENAL GLAND; ANDROGEN SYNTHESIS; AROMATIZATION; CATALYST; CHEMICAL REACTION; CLINICAL TRIAL; DISEASE COURSE; ENDOMETRIUM CANCER; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; OVARY; OVARY FUNCTION; POSTMENOPAUSE; REVIEW;

EID: 0037174891     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00140-8     Document Type: Article

References (81)

1. Zeleniuch-Jacquotte A., Akhmedkhanov A., Kato I., Koenig K.L., Shore R.E., Kim M.Y., Levitz M., et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br. J. Cancer. 84:(7):2001;975-981.
2. Austin H., Austin J.M., Partridge E.E., Hatch K.D., Shingleton H.M. Endometrial cancer, obesity and body fat distribution. Cancer Res. 51:1991;568-572.
3. Nyholm H.C.J., Nielsen A.L., Lyndrop J., Dreisler A., Hagen C. Plasma oestrogens in postmenopausal women with endometrial cancer. Br. J. Obstet. Gynaecol. 100:1993;1115-1119.
4. Potischman N., Hoover R.N., Brinton L.A., Siiteri P.K., Dorgan J.F., Swanson C.A., et al. Case-control study of endogenous steroid hormones and endometrial cancer. J. Natl. Cancer Inst. 88:1996;1127-1135.
5. Akhmedkhanov A., Zeleniuch-Jacquotte A., Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer. Ann. New York Acad. Sci. 943:2001;296-315.
6. Grodin J.M., Siiteri P.K., MacDonald P.C. Source of estrogen production in postmenopausal women. J. Clin. Endocrinol. Metab. 36:1973;207-214.
7. Adashi E.Y. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil. Steril. 62:1994;20-27.
8. Plouffe L. Ovaries, androgens and the menopause: practical applications. Semin. Reprod. Endocrinol. 16:1998;117-120.
9. Sluijmer AV. The postmenopausal ovary. Functional and morpholological aspects, Thesis Maastricht 1999. ISBN 90-9012802-6.
10. Ala-Fossi S.L., Maenpaa J., Aine R., Punnonen R. Ovarian testosterone secretion during perimenopause. Maturitas. 29:1998;239-245.
11. Bulun S.E., Economos K., Miller D., Simpson E.R. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J. Clin. Endocrinol. Metab. 79:1994;1831-1834.
12. Longcope C. Endocrine function of the postmenopausal ovary. J. Soc. Gynecol. Invest. 8:2001;S67-S68.
13. Bulun S.E., Noble L.S., Takayama K., Michael M.D., Agarwal V., Fisher C., et al. Endocrine disorders associated with inappropriately high aromatase expression. J. Steroid. Biochem. Mol. Biol. 61:1997;133-139.
14. Sasano H., Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr. Rev. 19:(5):1998;593-607.
15. Watanabe K., Sasano H., Harada N., Ozaki M., Niikura H., Sato S., Yajima A. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Am. J. Pathol. 146:1995;491-500.
16. Key T.J.A., Pike M.C. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br. J. Cancer. 57:1988;205-212.
17. Lucisano A., Russo N., Acampora M.G., Fabiano A., Fattibene M., Parlati E., Maniccia E., Dell''Acqua S. Ovarian and peripheral androgen levels in postmenopausal women: correlations with ovarian histology. Maturitas. 8:1986;57-65.
18. Sluijmer A.V., Heineman M.J., Koudstaal J., Theunissen P.H.M.H., De Jong F.H., Evers J.L.H. Relationship between ovarian production of estrone, estradiol, testosterone and androstenedione and the ovarian degree of stromal hyperplasia in postmenopausal women. Menopause. 5:1998;207-210.
19. Longcope C., Hunter R., Franz C. Steroid secretion by the postmenopausal ovary. Am. J. Obstet. Gynecol. 138:1980;564-568.
20. Mattingly R.F., Huang W.Y. Steroidogenesis of the menopausal and postmenopausal ovary. Am. J. Obstet. Gynecol. 103:1969;679-693.
21. Judd H.L., Lucas W.E., Yen S.S.C. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am. J. Obstet. Gynecol. 118:1974;793-798.
22. Judd H.L., Judd G.E., Lucas W.E., Yen S.S.C. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J. Clin. Endocrinol. Metab. 39:1974;1020-1024.
23. Heineman M.J., Sluijmer A.V., Evers J.L. Utero-ovarian vein blood sampling in postmenopausal women. Fertil. Steril. 60:1993;184-186.
24. Greenblatt R.B., Colle M.L., Mahesh V.B. Ovarian and adrenal steroid production in the postmenopausal woman. Obstet. Gynecol. 47:1976;383-387.
25. Sluijmer A.V., Heineman M.J., De Jong F.H., Evers J.L.H. Endocrine activity of the postmenopausal ovary: the effects of pituitary down-regulation and oophorectomy. J. Clin. Endocrinol. Metab. 80:1995;2163-2167.
26. Judd H.L., Lucas W.E., Yen S.S.C. Serum 17β-estradiol and estrone levels in postmenopausal women with and without endometrial cancer. J. Clin. Endocrinol. Metab. 43:1976;272-278.
27. Dowsett M., Cantwell B., Anshumala L., Jeffcoate S.L., Harris A.L. Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist Goserilin. J. Clin. Endocrin. Metabol. 66:1988;672-677.
28. Nagamani M., Doherty M.G., Smith E.R., Chandrasekhar Y. Increased bioactive luteinizing hormone levels in postmenopausal women with endometrial cancer. Am. J. Obstet. Gynecol. 167:1992;1825-1830.
29. Kobayashi M., Nakano R., Shima K. Immunohistochemical localization of pituitary gonadotropins and estrogen in human postmenopausal ovaries. Acta Obstet. Gynecol. Scand. 72:1993;76-80.
30. Inkster S.E., Brodie A.M.H. Expression of cytochrome P450 in premenopausal and postmenopausal human ovaries: an immunocytochemical study. J. Clin. Endocrinol. Metab. 73:1991;717-726.
31. Dennefors B.L., Janson P.O., Knutson F., Hamberger L. Steroid production and resposiveness to gonadotropin in isolated stromal tissue of human postmenopausal ovaries. Am. J. Obstet. Gynecol. 136:1980;997-1002.
32. Couzinet B., Meduri G., Lecce M.G., Young J., Brailly S., Loosfelt H., et al. The postmenopausal ovary is not a major androgen-producing gland. J. Clin. Endocrinol. Metab. 86:2001;5060-5066.
33. Longcope C. Editorial. The relationship of ovarian production of hormones and degree of ovarian stromal hyperplasia in postmenopausal women. Menopause. 5:1998;205.
34. Boss J.H., Scully R.E., Wegner K.H., Cohen R.B. Structural variations in the adult ovary: clinical significance. Obstet. Gynecol. 25:1965;747-764.
35. Woll E., Hertig A.T., Smith G.V.S., Johnson L.C. The ovary in endometrial carcinoma: with notes on the morphological history of the aging ovary. Am. J. Obstet. Gynecol. 56:1948;617-633.
36. Emons G., Fleckenstein G., Hinney B., Huschmand A., Heyl W. Hormonal interactions in endometrial cancer. Endocr. Rel. Cancer. 7:2000;227-242.
37. Sherman M.E. Theories of endometrial carcinogenis: a multidisciplinary approach. Mod. Pathol. 13:2000;295-308.
38. Carcangiu M.L., Chambers J.T., Voynick I.M., Pirro M., Schwartz P.E. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma: part I: clinical and histological correlations. Am. J. Clin. Pathol. 94:1990;247-254.
39. Umpierre S.A., Burke T.W., Tornos C., Ordonez N., Levenback C., Morris M. Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors. Int. J. Gynecol. Pathol. 13:1994;127-130.
40. Sherman M.E., Sturgeon L.A., Brinton L.A. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod. Pathol. 10:1997;963-968.
41. Henderson B.E., Ross R.K., Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 48:1988;246-253.
42. Kurman R.J., Kaminski P.F., Norris H.J. The behaviour of endometrial hyperplasia. A long-term study of 'untreated' hyperplasia in 170 patients. Cancer. 56:1985;403-412.
43. Carciangiu M.L., Chambers J.T. Uterine papillary serous carcinoma: a study of 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol. Oncol. 47:1992;298-305.
44. Moore T.D., Phillips P.H., Nerenstone S.R., Cheson B.D. Systemic treatment of advanced and recurrent endometrial carcinoma: current status and future directions. J. Clin. Oncol. 9:1991;1071-1088.
45. Mourits M.J.M., De Vries E.G.E., Willemse P.H.B., Ten Hoor K.A., Hollema H., Van der Zee A.G.J. Tamoxifen treatment and gynecologic side effects: a review. Obstet. Gynecol. 97:((5 Suppl 1)):2001;855-866.
46. Nagamani M., Hannigan E.V., Dillard E.A. Jr, Dinh T.V. Ovarian steroid secretion in postmenopausal women with and without endometrial cancer. J. Clin. Endocrinol. Metab. 62:1986;508-512.
47. Bremond A.G., Claustrat B., Rudigoz R.C., Seffert P., Corniau J. Estradiol, androstenedione, testosterone, and dehydroepiandrosterone sulfate in the ovarian and peripheral blood of postmenopausal patients with and without endometrial cancer. Gynecol. Oncol. 14:1982;119-124.
48. Mertens HJMM, Heineman MJ, De Jong FH, Evers JLH. Postmenopausal ovarian function and endometrial cancer. Hum Reprod 14, Abstractbook, June 1999; 89-90.
49. Nagamani M., Stuart C.A., Doherty M.G. Increased steroid production by the ovarian stromal tissue of postmenopausal women with endometrial cancer. J. Clin. Endocrinol. Metab. 74:1992;172-176.
50. Horie K., Takakura K., Imai K., Liao S., Mori T. Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium. Hum. Reprod. 7:1992;1461-1466.
51. Mertens H.J.M.M., Heineman M.J., Koudstaal J., Theunissen P., Evers J.L.H. Androgen receptor content in human endometrium. Eur. J. Obstet. Gynecol. Reprod. Biol. 70:1996;11-13.
52. Hackenberg R., Schulz K.D. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids. J. Steroid Biochem. Mol. Biol. 56:1996;113-117.
53. Legro R.S., Kunselman A.R., Miller S.A., Satyaswaroop P.G. Role of androgens in the growth of endometrial carcinoma: an in vivo animal model. Am. J. Obstet. Gynecol. 184:2001;303-308.
54. Nelson L.R., Bulun S.E. Estrogen production and action. J. Am. Acad. Dermatol. 45:2001;S116-S124.
55. Simpson E.R., Davis S.R. Minireview: aromatase and the regulation of estrogen biosynthesis-some new perspectives. Endocrinology. 142:2001;4589-9454.
56. Tseng L., Mazella J., Mann W.J., Chumas J. Estrogen synthesis in normal and malignant human endometrium. J. Clin. Endocrinol. Metab. 55:1982;1029-1031.
57. Yamamoto T., Kitawaki J., Urabe M., Honjo H., Tamura T., Noguchi T., et al. Estrogen productivity of endometrium and endometrial cancer tissue; influence of aromatase on proliferation of endometrial cancer cells. J. Steroid Biochem. Mol. Biol. 44:1993;463-468.
58. Sasano H., Kaga K., Sato S., Yajima A., Nagura H., Harada N. Aromatase P450 gene expression in endometrial carcinoma. Br. J. Cancer. 74:1996;1541-1544.
59. Yamaki J., Yamamoto T., Okada H. Aromatization of androstenedione by normal and neoplastic endometrium of the uterus. J. Steroid Biochem. Mol. Biol. 22:1985;63-66.
60. Bulun S.E., Mahendroo M.S., Simpson E.R. Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua. J. Clin. Endocrinol. Metab. 76:1993;1458-1463.
61. Noble L.S., Simpson E.R., Johns A., Bulun S.E. Aromatase expression in endometriosis. J. Clin. Endocrinol. Metab. 81:1996;174-179.
62. Kitawaki J., Noguchi T., Amatsu T., Maeda K., Tsukamoto K., Yamamoto T., et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol. Reprod. 57:1997;514-519.
63. Randolph J.F., Kipersztok S., Ayers J.W.T., Ansbacher R., Peegel H., Menon K.M.J. The effect of insulin on aromatase activity in isolated human endometrial glands and stroma. Am. J. Obstet. Gynecol. 157:1987;1534-1539.
64. Hemsell D.L., Grodin J.M., Brenner P.F., Siiteri P.K., MacDonald P.C. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J. Clin. Endocrinol. Metab. 38:1974;476-479.
65. MacDonald P.C., Edman C.D., Hemsell D.L., Porter J.C., Siiteri P.K. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am. J. Obstet. Gynecol. 130:1978;448-455.
66. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15:1994;342-355.
67. Berstein L.M., Imyanitov E.N., Suspitsin E.N., Grigoriev M.Y., Sokolov E.P., Togo A., et al. CYP19 gene polymorphism in endometrial cancer patients. J. Cancer Res. Clin. Oncol. 127:2001;135-138.
68. Haiman C.A., Hankinson S.E., Colditz G.A., Hunter D.J., De Vivo I. A polymorphism in CYP 17 and endometrial cancer risk. Cancer Res. 61:2001;3955-3960.
69. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., Baak J.P.A., Lees J.A., et al. Altered PTEN expression is a diagnostic marker for the earliest endometrial precancers. J. Natl. Cancer Inst. 92:2000;924-930.
70. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., Eng C. Changes in endometrial PTEN expression throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 85:2000;2334-2338.
71. Dahia P.L.M. PTEN, a unique tumor suppression gene. Endocr. Rel. Cancer. 7:2000;115-129.
72. Faquin W.C., Fitzgerald J.T., Lin M.C., Boyton K.A., Muto M.G., Mutter G.L. Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues. Am. J. Clin. Pathol. 113:2000;576-582.
73. MacDonald N.D., Salvesen H.B., Ryan A., Iversen O.E., Akslen L.A., Jacobs I.J. Frequency and prognostic index of microsatellite instability in a large population based study of endometrial carcinomas. Cancer Res. 60:2000;1750-1752.
74. Jovanovic A.S., Boynton K.A., Mutter G.L. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability. Cancer Res. 56:1996;1917-1921.
75. Sasano H., Sato S., Ito K., Yajima A., Nakamura J., Yoshihama M., et al. Effects of aromatase inhibitors on the pathobiology of human breast, endometrial and ovarian carcinoma. Endocr. Rel. Cancer. 6:1999;197-204.
76. Bonte J. Recent data about endometrial carcinoma: potential of anti-aromatase agents. Eur. J. Gynaec. Oncol. 22:2001;96-98.
77. de Jong P.C., van de Ven J., Nortier H.W., Maitimu-Smeele I., Donker T.H., Thijssen J.H., et al. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole. Cancer Res. 57:1997;2109-2111.
78. Murray R.L.M., Pitt P. Treatment of advanced metastatic breast cancer, carcinoma of the prostate and endometrial cancer with aminogluthethimidine. Nagel G.A., Santen R.J., Aminoglutethimide as an aromatase inhibitor in the treatment of cancer. 1984;109-122 Huber, Bern.
79. Yamamoto T., Fukuoka M., Fujimoto Y., Kitawaki J., Nakakoshi M., Yoshihama M., et al. Inhibitory effect of a new androstenedione derivate, 14α-hydroxy-4-androstene-3,6,17-trione (14α-OHAT) on aromatase activity of human uterine tumors. J. Steroid Biochem. Mol. Biol. 36:1990;517-521.
80. Bershtein L.M., Maksimov S.I., Gershfel'd E.D., Gamaiunova V.B., Meshkova I.E., Kovalenko I.G., et al. Neoadjuvant use of the aromatase inhibitor letrozole in uterine cancer: endocrine and clinical effects. Vopr. Onkol. 47:(5):2001;517-574.
81. Rose P.G., Brunetto V.L., VanLe L., Bell J., Walker J.L., Lee R.B. A phase III trial of Anastrozole in advanced recurrent or persistent endometrial carcinoma: a gynecologic oncology group study. Gynecol. Oncol. 78:2000;212-216.